Methylation of the cyclin D2 promoter appeared to be specific to breast cancer, however, promoter methylation of APC, RARbeta2 and RASSF1A in normal breast from breast cancer patients was associated with increased breasts cancer risk [67]. This evidence concerns the gene APC and breast carcinoma.